Protein Description

Gene Symbol ETS1
Entrez ID 2113
Uniprot ID P14921
Descriptionv-ets avian erythroblastosis virus E26 oncogene homolog 1
Chromosomal Locationchr11: 128,458,761-128,587,558
OntologyGO IDGO TermDefinitionEvidence

BP

GO:0001666

response to hypoxia

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.

IEA

BP

GO:0006955

immune response

Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.

TAS

BP

GO:0007565

female pregnancy

The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.

IEA

BP

GO:0008284

positive regulation of cell proliferation

Any process that activates or increases the rate or extent of cell proliferation.

IEA

BP

GO:0008285

negative regulation of cell proliferation

Any process that stops, prevents or reduces the rate or extent of cell proliferation.

TAS

BP

GO:0009612

response to mechanical stimulus

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.

IEA

BP

GO:0010595

positive regulation of endothelial cell migration

Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.

IMP

BP

GO:0010715

regulation of extracellular matrix disassembly

Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.

IEA

BP

GO:0021854

hypothalamus development

The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state.

IEA

BP

GO:0021983

pituitary gland development

The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.

IEA

BP

GO:0030578

PML body organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of PML bodies, a class of nuclear body; they react against SP100 auto-antibodies (PML = promyelocytic leukemia).

IDA

BP

GO:0032355

response to estradiol

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.

IEA

BP

GO:0034616

response to laminar fluid shear stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.

IEA

BP

GO:0044849

estrous cycle

A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur.

IEA

BP

GO:0045648

positive regulation of erythrocyte differentiation

Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.

IDA

BP

GO:0045765

regulation of angiogenesis

Any process that modulates the frequency, rate or extent of angiogenesis.

IMP

BP

GO:0045766

positive regulation of angiogenesis

Any process that activates or increases angiogenesis.

IEA

BP

GO:0045893

positive regulation of transcription, DNA-templated

Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.

IDA

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IDA

BP

GO:0048870

cell motility

Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.

IMP

BP

GO:0050728

negative regulation of inflammatory response

Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.

IEA

BP

GO:0050729

positive regulation of inflammatory response

Any process that activates or increases the frequency, rate or extent of the inflammatory response.

IDA

BP

GO:0051272

positive regulation of cellular component movement

Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.

IMP

BP

GO:0060055

angiogenesis involved in wound healing

Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury.

IEA

BP

GO:0061614

pri-miRNA transcription from RNA polymerase II promoter

The cellular synthesis of primary microRNA (pri-miRNA) transcripts from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. pri-miRNA transcripts are subsequently processed to produce the ~22nt miRNAs that function in gene regulation.

IDA

BP

GO:0070301

cellular response to hydrogen peroxide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.

IEA

BP

GO:0070555

response to interleukin-1

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.

IEA

BP

GO:1904996

positive regulation of leukocyte adhesion to vascular endothelial cell

Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.

IMP

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

IDA|TAS

CC

GO:0005667

transcription factor complex

A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

IEA

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IEA

MF

GO:0000981

RNA polymerase II transcription factor activity, sequence-specific DNA binding

Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.

IBA

MF

GO:0000982

transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding

Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II.

IDA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

ISS

MF

GO:0003700

transcription factor activity, sequence-specific DNA binding

Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.

IDA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008134

transcription factor binding

Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.

NAS

MF

GO:0035035

histone acetyltransferase binding

Interacting selectively and non-covalently with the enzyme histone acetyltransferase.

IEA

MF

GO:0043565

sequence-specific DNA binding

Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.

IEA

Domain IDDescription

IPR000418

Ets domain

IPR003118

Pointed domain

IPR011991

Winged helix-turn-helix DNA-binding domain

IPR013761

Sterile alpha motif/pointed domain

IPR016311

Transforming protein C-ets

Pathway IDPathway TermPathway Source

hsa04014

Ras signaling pathway

KEGG

hsa04320

Dorso-ventral axis formation

KEGG

hsa05166

HTLV-I infection

KEGG

hsa05200

Pathways in cancer

KEGG

hsa05211

Renal cell carcinoma

KEGG

WP23

B Cell Receptor Signaling Pathway

WikiPathways

WP366

TGF-beta Signaling Pathway

WikiPathways

WP2064

Neural Crest Differentiation

WikiPathways

WP2864

Apoptosis-related network due to altered Notch3 in ovarian cancer

WikiPathways

WP3888

VEGFA-VEGFR2 Signaling Pathway

WikiPathways

h_keratinocytePathway

Keratinocyte Differentiation

BioCarta

h_etsPathway

METS affect on Macrophage Differentiation

BioCarta

UMLS CUIUMLS Term

C0007570

Celiac Disease

C0024141

Lupus Erythematosus, Systemic

C0035126

Reperfusion Injury

TissueCell Type

appendix

lymphoid tissue

bone marrow

hematopoietic cells

lymph node

non-germinal center cells

tonsil

germinal center cells

tonsil

non-germinal center cells

No databases found.

Pubmed IDAuthorYearTitle

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene SymbolEntrez IDUniprot IDScore

FLT1

2321

P17948

0.0

HRAS

3265

P01112

0.0

JAK1

3716

P23458

0.0

KDR

3791

P35968

0.0

NPR1

4881

P16066

0.0

STAT1

6772

P42224

0.0

AARS

16

P49588

0.49

EPRS

2058

P07814

0.49

GNAS

2778

P84996

0.49

HMGB1

3146

P09429

0.49

JUND

3727

P17535

0.49

PFDN5

5204

Q99471

0.49

RAD23B

5887

P54727

0.49

SET

6418

Q01105

0.49

SMARCA2

6595

P51531

0.49

TTC3

7267

P53804

0.49

EIF3A

8661

Q14152

0.49

SLIT2

9353

O94813

0.49

MED23

9439

Q9ULK4

0.49

PCNX1

22990

Q96RV3

0.49

ZFR

51663

Q96KR1

0.49

ELP2

55250

Q6IA86

0.49

LAS1L

81887

Q9Y4W2

0.49

TCEAL3

85012

Q969E4

0.49

WDR17

116966

Q8IZU2

0.49

C1orf52

148423

Q8N6N3

0.49

ZMAT2

153527

Q96NC0

0.49

FAM171A1

221061

Q5VUB5

0.49

STAT6

6778

P42226

0.52

APP

351

P05067

0.56

ATF2

1386

P15336

0.56

NCL

4691

P19338

0.56

TBP

6908

P20226

0.56

ARL6IP4

51329

Q66PJ3

0.56

NR3C1

2908

P04150

0.62

PARP1

142

P09874

0.63

MAPK14

1432

Q16539

0.63

CTNNB1

1499

P35222

0.63

EPAS1

2034

Q99814

0.63

XRCC6

2547

P12956

0.63

PKM

5315

P14618

0.63

PLEC

5339

Q15149

0.63

TCF4

6925

P15884

0.63

XRCC5

7520

P13010

0.63

SRA1

10011

Q9HD15

0.63

GATA3

2625

P23771

0.65

NFKB1

4790

P19838

0.65

NCOR1

9611

O75376

0.65

PRKDC

5591

P78527

0.68

SMAD3

4088

P84022

0.69

SP1

6667

P08047

0.69

ATP2B1

490

P20020

0.72

CHI3L2

1117

Q15782

0.72

MEIS1

4211

O00470

0.72

THUMPD1

55623

Q9NXG2

0.72

TP53

7157

P04637

0.74

ETS1

2113

P14921

0.75

ARID4B

51742

Q4LE39

0.75

CREBBP

1387

Q92793

0.82

PIAS4

51588

Q8N2W9

0.82

TDP2

51567

O95551

0.84

SRC

6714

P12931

0.85

SP100

6672

P23497

0.89

CREB1

1385

P16220

0.0

CDC5L

988

Q99459

0.49

CENPB

1059

P07199

0.49

CYP51A1

1595

Q16850

0.49

NEFM

4741

P07197

0.49

TSC1

7248

Q92574

0.49

EIF3D

8664

O15371

0.49

PHF14

9678

O94880

0.49

SV2A

9900

Q7L0J3

0.49

CPLX2

10814

Q6PUV4

0.49

SERBP1

26135

Q8NC51

0.49

RPS6KC1

26750

Q96S38

0.49

ACAD8

27034

Q9UKU7

0.49

CHMP4A

29082

Q9BY43

0.49

PPME1

51400

Q9Y570

0.49

ZNHIT6

54680

Q9NWK9

0.49

SCOC

60592

Q9UIL1

0.49

NOMO2

283820

Q5JPE7

0.49

CAMK2B

816

Q13554

0.52

STAT5B

6777

P51692

0.55

HTATIP2

10553

Q9BUP3

0.55

APLP2

334

Q06481

0.56

RUNX1T1

862

Q06455

0.56

RPL13A

23521

P40429

0.56

CAMK2A

815

Q9UQM7

0.59

POU1F1

5449

P28069

0.59

FOS

2353

P01100

0.62

MAPK3

5595

P27361

0.62

ELAVL1

1994

Q15717

0.63

PTEN

5728

P60484

0.63

RBBP6

5930

Q7Z6E9

0.63

TAL1

6886

P17542

0.63

NCOA3

8202

Q9Y6Q9

0.63

NCOA1

8648

Q15788

0.63

KAT2B

8850

Q92831

0.63

ZBTB7A

51341

O95365

0.63

AR

367

P10275

0.65

TLX1

3195

P31314

0.65

PAX5

5079

Q02548

0.65

TLX3

30012

O43711

0.65

EP300

2033

Q09472

0.7

SRSF11

9295

Q05519

0.73

SUMO2

6613

P61956

0.74

BRCA1

672

P38398

0.75

RUNX2

860

Q13950

0.75

RUNX1

861

Q01196

0.75

MAF

4094

O75444

0.75

SPI1

6688

P17947

0.75

EIF5B

9669

O60841

0.75

RFWD2

64326

Q8NHY2

0.75

C17orf62

79415

Q9BQA9

0.75

MAPK1

5594

P28482

0.78

MAPK7

5598

Q13164

0.79

ETS2

2114

P15036

0.85

JUN

3725

P05412

0.88

UBE2I

7329

P63279

0.88

DAXX

1616

Q9UER7

0.89